Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 71,183 | -63,734 | -54,188 | -39,696 | -84,936 |
| Depreciation Amortization | 3,563 | 2,907 | 3,198 | 4,577 | 4,464 |
| Accounts receivable | -6,147 | N/A | -2,041 | 2,812 | -3,000 |
| Other Working Capital | -5,387 | -4,383 | -1,788 | -5,892 | -18,263 |
| Other Operating Activity | -139,538 | 9,195 | 17,810 | -5,284 | 36,070 |
| Operating Cash Flow | $-76,326 | $-56,015 | $-37,009 | $-43,483 | $-65,665 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -39,363 | -36,812 | 335 | -25,568 | 70,213 |
| PPE Investments | -7,975 | -2,428 | -127 | 1,604 | -4,151 |
| Net Acquisitions | 152,366 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $105,028 | $-39,240 | $208 | $-23,964 | $66,062 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 20,000 | N/A | N/A | N/A |
| Common Stock Issued | 26,077 | 85,628 | 37,389 | 46,960 | 24,861 |
| Other Financing Activity | -37 | -1,489 | -332 | -3,787 | 0 |
| Financing Cash Flow | $26,040 | $104,139 | $37,057 | $43,173 | $24,861 |
| Beginning Cash Position | 23,695 | 14,811 | 14,555 | 38,829 | 13,571 |
| End Cash Position | 78,437 | 23,695 | 14,811 | 14,555 | 38,829 |
| Net Cash Flow | $54,742 | $8,884 | $256 | $-24,274 | $25,258 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,326 | -56,015 | -37,009 | -43,483 | -65,665 |
| Capital Expenditure | -7,975 | -2,446 | -331 | -130 | -4,151 |
| Free Cash Flow | -84,301 | -58,461 | -37,340 | -43,613 | -69,816 |